RJA
MYGN icon

Raymond James & Associates’s Myriad Genetics MYGN Stock Holding History

Raymond James & Associates’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.51M Buy
+55,204
New +$1.49M ﹤0.01% 2417
2021
Q4 		– Sell
-9,542
Closed -$308K – 4235
2021
Q3 		$308K Sell
9,542
-52
-0.5% -$1.73K ﹤0.01% 3393
2021
Q2 		$293K Buy
+9,594
New +$277K ﹤0.01% 3449
2020
Q2 		– Sell
-18,155
Closed -$260K – 3613
2020
Q1 		$260K Buy
18,155
+3,049
+20% +$64.4K ﹤0.01% 2863
2019
Q4 		$411K Buy
+15,106
New +$416K ﹤0.01% 2875
2019
Q2 		– Sell
-9,493
Closed -$315K – 3714
2019
Q1 		$315K Buy
9,493
+1,923
+25% +$58.5K ﹤0.01% 2956
2018
Q4 		$220K Buy
7,570
+651
+9% +$23.4K ﹤0.01% 3064
2018
Q3 		$318K Buy
+6,919
New +$308K ﹤0.01% 2985
2018
Q1 		– Sell
-6,331
Closed -$217K – 3542
2017
Q4 		$217K Sell
6,331
-2,766
-30% -$93.3K ﹤0.01% 3010
2017
Q3 		$329K Buy
+9,097
New +$259K ﹤0.01% 2732
2015
Q1 		– Sell
-10,173
Closed -$346K – 2378
2014
Q4 		$346K Buy
10,173
+66
+0.7% +$2.34K ﹤0.01% 2074
2014
Q3 		$390K Sell
10,107
-19,425
-66% -$725K ﹤0.01% 1942
2014
Q2 		$1.15M Buy
+29,532
New +$1.1M 0.01% 1412
2013
Q3 		– Sell
-17,552
Closed -$472K – 1953
2013
Q2 		$472K Buy
+17,552
New +$509K ﹤0.01% 1540

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Raymond James & Associates's MYGN Position: Q3 2024 in Review

Raymond James & Associates opened a new position in Myriad Genetics (MYGN) in Q3 2024: 55,204 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #2417 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in MYGN as recently as Q3 2021.

Raymond James & Associates first reported a position in MYGN in Q2 2013 and has held it in 14 quarters since. 246 funds tracked by Wall St. Rank hold MYGN as of Q3 2024.

  • Raymond James & Associates held 55,204 shares of Myriad Genetics worth $1.51M as of Q3 2024.
  • Myriad Genetics was a new Raymond James & Associates position in Q3 2024.
  • Myriad Genetics made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2417 holding.
  • Raymond James & Associates first reported a position in Myriad Genetics in Q2 2013 and has held it in 14 quarters since.
  • 246 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.